Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
23.23
-0.36 (-1.53%)
At close: Jan 22, 2025, 4:00 PM
23.41
+0.18 (0.77%)
After-hours: Jan 22, 2025, 5:32 PM EST
Immunovant Market Cap
Immunovant has a market cap or net worth of $3.41 billion as of January 22, 2025. Its market cap has decreased by -39.39% in one year.
Market Cap
3.41B
Enterprise Value
2.94B
1-Year Change
-39.39%
Ranking
Category
Stock Price
$23.23
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $3.41B, an increase of 2,641.55%. That is a compound annual growth rate of 80.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |